Revelation Biosciences, Inc (REVB) insider trading

Every open-market stock purchase and sale by Revelation Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: George F Tidmarsh (Director), $29K, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent REVB insider trades

DateInsiderTradeValue
Apr 30, 2026Chester Stanley Zygmont III (CFO)Sold (not open market)$14.6K
Apr 30, 2026James Rolke (CEO)Sold (not open market)$11.4K
Feb 4, 2026Chester Stanley Zygmont III (CFO)Sold (not open market)$21.6K
Feb 3, 2026James Rolke (CEO)Sold (not open market)$15.8K
Feb 3, 2026Lakhmir S Chawla (Insider)Sold (not open market)$4.2K
Feb 3, 2026Jennifer Carver (Insider)Sold (not open market)$3.1K
Feb 3, 2026Jess Roper (Insider)Sold (not open market)$2.9K
Jan 8, 2026James Rolke (CEO)Bought (not open market)$480K
Jan 8, 2026Chester Stanley Zygmont III (CFO)Bought (not open market)$70.3K
Jan 8, 2026Jess Roper (Insider)Bought (not open market)$37.8K
Jan 8, 2026Lakhmir S Chawla (Insider)Bought (not open market)$37.8K
Jan 8, 2026Jennifer Carver (Insider)Bought (not open market)$37.8K
Oct 29, 2025Chester Stanley Zygmont III (CFO)Bought (not open market)$500K
Oct 29, 2025James Rolke (CEO)Bought (not open market)$500K
Oct 29, 2025Jennifer Carver (Insider)Bought (not open market)$20K
Oct 29, 2025Jess Roper (Insider)Bought (not open market)$20K
Oct 29, 2025Lakhmir S Chawla (Insider)Bought (not open market)$20K

Who's trading REVB

Get free alerts when an insider at Revelation Biosciences, Inc files a new trade →